A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In Vivo.
Drug Metab Dispos
; 43(11): 1718-26, 2015 Nov.
Article
in En
| MEDLINE
| ID: mdl-26265743
Full text:
1
Database:
MEDLINE
Main subject:
Enzyme Activators
/
Cytochrome P-450 CYP3A
/
Androgen Receptor Antagonists
/
Flutamide
Type of study:
Prognostic_studies
Language:
En
Journal:
Drug Metab Dispos
Year:
2015
Type:
Article